NCT07586618
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07586618
Title First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. (ALT-101)
Acronym ALT-101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Allterum Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Colorado RECRUITING Aurora Colorado 80045 United States Details
Riley Children's Hosptial RECRUITING Indianapolis Indiana 46202 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Cincinnati Children's Hospital Medical Center NOT_YET_RECRUITING Cincinnati Ohio 45229 United States Details
Children's Hospital of Philadelphia NOT_YET_RECRUITING Philadelphia Pennsylvania 19104 United States Details
Cook Children's Medical Center RECRUITING Fort Worth Texas 76104 United States Details
Texas Children's Hospital RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field